Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $669.0600 (-3.55%) ($667.7000 - $669.0600) on Wed. Mar. 23, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.51% (three month average) | RSI | 78 | Latest Price | $669.0600(-3.55%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.3% a day on average for past five trading days. | Weekly Trend | REGN advances 5.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(58%) DIA(41%) IWD(40%) XLV(40%) SPLV(38%) | Factors Impacting REGN price | REGN will decline at least -0.755% in a week (0% probabilities). VIXM(-19%) TBT(-11%) UUP(-8%) EDOC(-5%) VXX(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.755% (StdDev 1.51%) | Hourly BBV | -2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $685.57(-2.41%) | 10 Day Moving Average | $671.2(-0.32%) | 20 Day Moving Average | $644.74(3.77%) | To recent high | -3.5% | To recent low | 12.4% | Market Cap | $70.94b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |